Total Payments
$5,646
2024 Payments
$1,088
Companies
34
Transactions
321
Medicare Patients
11,374
Medicare Billing
$763,125
Payment Breakdown by Category
Food & Beverage$5,273 (93.4%)
Education$372.88 (6.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,273 | 316 | 93.4% |
| Education | $372.88 | 5 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $824.17 | 31 | $0 (2024) |
| ABBVIE INC. | $823.08 | 64 | $0 (2024) |
| PFIZER INC. | $509.95 | 28 | $0 (2024) |
| Novo Nordisk Inc | $456.56 | 27 | $0 (2024) |
| Lilly USA, LLC | $441.12 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $392.84 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $308.35 | 18 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $242.42 | 16 | $0 (2021) |
| Amgen Inc. | $220.20 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $209.41 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,088 | 52 | Astellas Pharma US Inc ($188.55) |
| 2023 | $1,201 | 66 | Astellas Pharma US Inc ($256.33) |
| 2022 | $714.36 | 43 | ABBVIE INC. ($191.67) |
| 2021 | $746.08 | 50 | AbbVie Inc. ($267.84) |
| 2020 | $582.85 | 36 | Endo Pharmaceuticals Inc. ($61.91) |
| 2019 | $816.13 | 46 | PFIZER INC. ($179.94) |
| 2018 | $473.73 | 26 | PFIZER INC. ($113.11) |
| 2017 | $24.42 | 2 | Merck Sharp & Dohme Corporation ($24.42) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 13 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Neuroscience | ||||||
| 11/14/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: UROLOGY | ||||||
| 11/01/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $12.07 | General |
| Category: Cardiovascular | ||||||
| 10/30/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Diabetes | ||||||
| 10/25/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: UROLOGY | ||||||
| 10/23/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/22/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $71.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/16/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 10/11/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Respiratory | ||||||
| 08/28/2018 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Endocrinology | ||||||
| 08/21/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/07/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/02/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 07/31/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/19/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $12.16 | General |
| Category: Cardiovascular | ||||||
| 06/18/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug) | Food and Beverage | In-kind items and services | $36.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/12/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Diabetes | ||||||
| 11/15/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/26/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,362 | 2,703 | $540,047 | $194,402 |
| 2022 | 22 | 1,967 | 2,299 | $461,920 | $166,083 |
| 2021 | 25 | 3,227 | 3,648 | $526,537 | $210,861 |
| 2020 | 27 | 3,818 | 4,792 | $430,931 | $191,778 |
Total Patients
11,374
Total Services
13,442
Medicare Billing
$763,125
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 627 | 891 | $259,975 | $77,106 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 396 | 396 | $117,859 | $50,096 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 233 | $47,998 | $14,379 | 30.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 53 | 53 | $23,850 | $14,331 | 60.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 57 | 57 | $21,432 | $8,966 | 41.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 88 | 88 | $10,736 | $6,326 | 58.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 29 | 29 | $13,543 | $4,539 | 33.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 26 | 26 | $9,802 | $4,247 | 43.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 201 | 201 | $8,643 | $3,632 | 42.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 89 | 89 | $4,450 | $2,686 | 60.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,016 | $1,837 | 30.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 32 | 33 | $4,323 | $1,821 | 42.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 58 | 58 | $2,900 | $1,709 | 58.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $2,688 | $802.98 | 29.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 277 | 300 | $1,500 | $648.46 | 43.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 58 | $1,856 | $530.30 | 28.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $850.00 | $274.32 | 32.3% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 38 | 56 | $840.00 | $229.07 | 27.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 15 | $375.00 | $133.28 | 35.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 22 | 22 | $264.00 | $70.44 | 26.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 21 | 21 | $147.00 | $38.34 | 26.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 12 | 15 | $0.15 | $0.10 | 66.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 535 | 803 | $234,279 | $70,160 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 316 | 316 | $94,168 | $41,545 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 179 | $36,874 | $10,874 | 29.5% |
About Dr. Patrick Kindregan, DO
Dr. Patrick Kindregan, DO is a Family Medicine healthcare provider based in Cumming, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2013. The National Provider Identifier (NPI) number assigned to this provider is 1821436999.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Kindregan, DO has received a total of $5,646 in payments from pharmaceutical and medical device companies, with $1,088 received in 2024. These payments were reported across 321 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,273).
As a Medicare-enrolled provider, Kindregan has provided services to 11,374 Medicare beneficiaries, totaling 13,442 services with total Medicare billing of $763,125. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Cumming, GA
- Active Since 06/11/2013
- Last Updated 05/18/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821436999
Products in Payments
- UBRELVY (Drug) $321.65
- MOUNJARO (Drug) $259.95
- MYRBETRIQ (Drug) $249.28
- TRELEGY ELLIPTA (Drug) $234.40
- JANUVIA (Drug) $204.19
- Ozempic (Drug) $191.76
- VRAYLAR (Drug) $175.60
- JARDIANCE (Drug) $172.33
- Veozah (Drug) $169.45
- NURTEC ODT (Drug) $161.42
- QULIPTA (Drug) $136.46
- SYNTHROID (Drug) $129.02
- EVENITY (Biological) $124.45
- PREVNAR - 13 (Biological) $117.47
- ELIQUIS (Drug) $110.09
- FARXIGA (Drug) $107.56
- Rybelsus (Drug) $106.36
- NASCOBAL (Drug) $96.47
- Wegovy (Drug) $96.25
- SHINGRIX (Biological) $89.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cumming
Charles Decook, Md, MD
Family Medicine — Payments: $27.1M
Family Medicine $27.1M
Dr. Nadine Halliburton-Foster, Md, MD
Family Medicine — Payments: $171,404
Family Medicine $171,404
Michelle Jenkins, M.d, M.D
Family Medicine — Payments: $16,081
Family Medicine $16,081
Raymond Easley, D.o, D.O
Family Medicine — Payments: $9,775
Family Medicine $9,775
Jeevana Krishna, M.d, M.D
Family Medicine — Payments: $8,673
Family Medicine $8,673
Ryan Schott, Pa-C, PA-C
Family Medicine — Payments: $8,211
Family Medicine $8,211